Hepatocellular carcinoma with portal vein tumor thrombosis: Clinical characteristics, prognosis, and patient survival analysis

Digestive Diseases and Sciences

Volumn 52, Issue 11, 2007, Pages 3290-3295

  Takizawa, Daichi ^a   Kakizaki, Satoru ^a   Sohara, Naondo ^a   Sato, Ken ^a   Takagi, Hitoshi ^a   Arai, Hirotaka ^b   Katakai, Kenji ^c   Kojima, Akira ^d   Matsuzaki, Yutaka ^e   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MAEBASHI RED CROSS HOSPITAL   (Japan)

^c Isesaki Municipal Hospital   (Japan)

^d Kiryu Kosei General Hospital   (Japan)

^e National Hospital Organization   (Japan)

Author keywords

Hepatocellular carcinoma; Portal vein tumor thrombosis; Survival analysis

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; GROUPS BY AGE; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; BIOPSY; CARCINOMA, HEPATOCELLULAR; CAUSE OF DEATH; FEMALE; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL VEIN; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; VENOUS THROMBOSIS;

EID: 34848902988     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9808-2     Document Type: Article

References (20)

1. Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, Bru C, Rodes J, Bruix J (1999) Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29:62-67
2. Pawarode A, Voravud N, Sriuranpong V, Kullavanijaya P, Patt YZ (1998) Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients. Am J Clin Oncol 21:386-391
3. Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY (1997) The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer 79:2087-2094
4. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, Ohnishi K (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56:918-928
5. Fujii T, Takayasu K, Muramatsu Y, Moriyama N, Wakao F, Kosuge T, Takayama T, Makuuchi M, Yamasaki S, Okazaki N (1993) Hepatocellular carcinoma with portal tumor thrombus: analysis of factors determining prognosis. Jpn J Clin Oncol 23:105-109
6. Sakurai M, Okamura J, Kuroda C (1984) Transcatheter chemo-embolization effective for treating hepatocellular carcinoma: A histopathologic study. Cancer 54:387-392
7. Bruix J (1997) Treatment of hepatocellular carcinoma. Hepatology 25:259-262
8. Friedman M (1983) Primary hepatocellular cancer-present results and future prospects. Int J Radiat Oncol Biol Phys 9:1841-1850
9. Iwamiya T, Sawada S, Ohta Y (1994) Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system. Cancer Chemother Pharmacol 33:S134-S138
10. Une Y, Uchino J, Yasuhara M, Misawa K, Kamiyama T, Shimamura T, Sato N, Nakajima Y, Hata Y (1993) Intra-arterial infusion chemotherapy on unresectable hepatocellular carcinoma under occlusion of hepatic arterial flow. Clin Ther 15:347-354
11. Toyoda H, Nakano S, Kumada T, Takeda I, Sugiyama K, Osada T, Kiriyama S, Suga T, Takahashi M (1995) The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma. Oncology 52:295-299
12. Ando E, Yamashita F, Tanaka M, Tanigawa K (1997) A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein. Cancer 79:1890-1896
13. Itamoto T, Nakahara H, Tashiro H, Haruta N, Asahara T, Naito A, Ito K (2002) Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombosis of the portal vein. J Surg Oncol 80:143-148
14. Ando E, Tanaka M, Yamashita F, Kuromatsu R, Yatani S, Fukumori K, Sumie S, Yano Y, Okuda K, Sata M (2002) Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases. Cancer 95:588-595
15. Llovet JM, Beaugrand M (2003) Hepatocellular carcinoma: present status and future prospects. J Hepatol 38:S136-S149
16. Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdej C, Sala M, Bru C, Rodes J, Bruix J (1999) Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29:62-67
17. Chung YH, Song H, Song BC, Lee GC, Koh MS, Yoon HK, Lee YS, Sung KB, Suh DJ (2000) Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-a for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Cancer 88:1986-1991
18. The Liver Cancer Study Group of Japan (1994) Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma. Cancer 74:2772-2780
19. Sakon M, Nagano H, Dono K, Nakamori S, Umeshita K, Yamada A, Kawata S, Imai Y, Iijima S, Monden M (2002) Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer 94:435-442
20. Meric F, Patt YZ, Curley SA, Chase J, Roh MS, Vanthey JN, Ellis LM (2000) Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol 7:490-495